Iovance Biotherapeutics (IOVA) Provides Regulatory Update for Lifileucel Potency Assays, BLA Submission Now Expected H1 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. FDX
4. ABBV
5. META
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Iovance Biotherapeutics (IOVA) Provides Regulatory Update for Lifileucel Potency Assays, BLA Submission Now Expected H1 2022
(NASDAQ: IOVA) Delayed: 4.44 --0 (-0%)
Previous Close $4.44    52 Week High $ 
Open $4.44    52 Week Low $ 
Day High $4.44    P/E N/A 
Day Low $4.44    EPS $ 
Volume 17,612